产品标题 产品货号 产品规格 厂家
Serum amyloid A4, constitutive (SAA4) from ORIGENE TECHNOLOGIESLY416589100 ugORIGENE TECHNOLOGIES
Serum amyloid A-like 1 (SAAL1) from ORIGENE TECHNOLOGIESLY408677100 ugORIGENE TECHNOLOGIES
Serum amyloid A1 (SAA1), transcript variant 1 from ORIGENE TECHNOLOGIESLY424788100 ugORIGENE TECHNOLOGIES
Serum amyloid A1 (SAA1), transcript variant 2 from ORIGENE TECHNOLOGIESLY403693100 ugORIGENE TECHNOLOGIES
Serum amyloid A2 (SAA2), transcript variant 1 from ORIGENE TECHNOLOGIESLY410691100 ugORIGENE TECHNOLOGIES
Serum/glucocorticoid regulated kinase family, member 3 (SGK3), transcript variant 1 from ORIGENE TECHNOLOGIESLY415716100 ugORIGENE TECHNOLOGIES
Serum deprivation response (SDPR) from ORIGENE TECHNOLOGIESLY417841100 ugORIGENE TECHNOLOGIES
Serum/glucocorticoid regulated kinase family, member 3 (SGK3), transcript variant 2 from ORIGENE TECHNOLOGIESLY406888100 ugORIGENE TECHNOLOGIES
Serum/glucocorticoid regulated kinase family, member 3 (SGK3), transcript variant 3 from ORIGENE TECHNOLOGIESLY422403100 ugORIGENE TECHNOLOGIES
Serum/glucocorticoid regulated kinase 1 (SGK1), transcript variant 1 from ORIGENE TECHNOLOGIESLY417159100 ugORIGENE TECHNOLOGIES
Serum/glucocorticoid regulated kinase 1 (SGK1), transcript variant 2 from ORIGENE TECHNOLOGIESLY428312100 ugORIGENE TECHNOLOGIES
Serum/glucocorticoid regulated kinase 1 (SGK1), transcript variant 4 from ORIGENE TECHNOLOGIESLY428314100 ugORIGENE TECHNOLOGIES
Serum/glucocorticoid regulated kinase 2 (SGK2), transcript variant 1 from ORIGENE TECHNOLOGIESLY406797100 ugORIGENE TECHNOLOGIES
Serum/glucocorticoid regulated kinase 2 (SGK2), transcript variant 2 from ORIGENE TECHNOLOGIESLY414080100 ugORIGENE TECHNOLOGIES
Serum response factor binding protein 1 (SRFBP1) from ORIGENE TECHNOLOGIESLY407457100 ugORIGENE TECHNOLOGIES
Serum response factor (c-fos serum response element-binding transcription factor) (SRF) from ORIGENE TECHNOLOGIESLY418874100 ugORIGENE TECHNOLOGIES
Seryl-tRNA synthetase 2, mitochondrial (SARS2), nuclear gene encoding mitochondrial protein, transcript variant 1 from ORIGENE TECHNOLOGIESLY431453100 ugORIGENE TECHNOLOGIES
Seryl-tRNA synthetase (SARS) from ORIGENE TECHNOLOGIESLY416590100 ugORIGENE TECHNOLOGIES
Seryl-tRNA synthetase 2, mitochondrial (SARS2), nuclear gene encoding mitochondrial protein, transcript variant 2 from ORIGENE TECHNOLOGIESLY413512100 ugORIGENE TECHNOLOGIES
SESN2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4013861 kitORIGENE TECHNOLOGIES
SESN1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4113051 kitORIGENE TECHNOLOGIES
SESN3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4198181 kitORIGENE TECHNOLOGIES
Sesn1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5156171 kitORIGENE TECHNOLOGIES
Sesn3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5156191 kitORIGENE TECHNOLOGIES
Sesn2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5156181 kitORIGENE TECHNOLOGIES
SESN2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30138610 ugORIGENE TECHNOLOGIES
SESTD1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4079761 kitORIGENE TECHNOLOGIES
Sestd1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5156201 kitORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5158195x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5184465x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5191365x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5196815x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5199545x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5214445x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5214505x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5216015x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5217135x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5221205x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5221395x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5221505x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5227625x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5238025x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5244725x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5259375x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5278015x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5286335x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5286515x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5287335x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5293385x5umORIGENE TECHNOLOGIES
Human Endometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIESCS5296295x5umORIGENE TECHNOLOGIES
 |< < 3682 3683 3684 3685 3686 3687 3688 3689 3690 > >| 第 3683/6274 页